Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial

BACKGROUND: The impact of baseline anemia in a contemporary acute coronary syndrome (ACS) population undergoing percutaneous coronary intervention in the era of predominant radial artery access, potent P2Y12 inhibition, and rare use of glycoprotein IIb/IIIa inhibitors has not been adequately studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Wester, Axel, Attar, Rubina, Mohammad, Moman Aladdin, Andell, Pontus, Hofmann, Robin, Jensen, Jens, Szummer, Karolina, Erlinge, David, Koul, Sasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759912/
https://www.ncbi.nlm.nih.gov/pubmed/31387441
http://dx.doi.org/10.1161/JAHA.119.012741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759912/
https://www.ncbi.nlm.nih.gov/pubmed/31387441
http://dx.doi.org/10.1161/JAHA.119.012741

Ejemplares similares